(6-Butoxy-5-methylpyridin-3-yl)boronic acid, 95.0%, 10g

5-((3aS,8aS)-2,2-Dimethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)-5H-dibenzo[b,f]azepine, 97%, 100mg

Methyl 4-(piperidin-4-ylmethyl)benzoate hydrochloride, 95.0%, 250mg

Tungsten boride powder 99.5% 50 g

4-Mercaptobenzenesulfonic acid, 95.0%, 100mg

2-Chloro-6-methoxypyridine>98.0%(GC)5g

HPLC column NUCLEODUR® NH2 5 µm, 125 mm, 4 mm, 1 Piece(s)

2-Cyano-6-methylpyridine, 95.0%, 500g

ETHYL 2-(5-FLUORO-1H-INDAZOL-3-YL)ACETATE, 97%, 100mg

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-phenylpentanoic acid, 98%, 250mg

Methyl 6-chloro-4-methoxy-2-methylnicotinate, 95%, 1g

Tripalmitin>85.0%(GC)25g

6-BROMO-5-FLUORO-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE, 95.0%, 250mg